Among the participants given R-CHOP (including the non-randomised group), MYC rearrangement, double-hit lymphoma, and dual high MYC and BCL-2 mRNA expression were significantly associated with inferior progression-free survival after controlling for IPI (data not shown). The gene discussed is MYC; the disease is lymphoma.